ERBB2 and breast carcinoma: HER-2 expression is an important factor in therapeuticdecision-making of breast cancer, since HER-2 protein (HER-2 gene product) is targeted for specific treatment by humanizedrecombinant monoclonal antibody Trastuzumab.